Inventiva

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Inventiva and buy or sell other stocks, options, and ETFs commission-free!

About IVA

Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. 

CEO
Frédéric Cren
CEOFrédéric Cren
Employees
113
Employees113
Headquarters
Daix, Bourgogne-Franche-Comte
HeadquartersDaix, Bourgogne-Franche-Comte
Founded
2011
Founded2011
Employees
113
Employees113

IVA Key Statistics

Market cap
226.18M
Market cap226.18M
Price-Earnings ratio
-2.16
Price-Earnings ratio-2.16
Dividend yield
Dividend yield
Average volume
61.12K
Average volume61.12K
High today
$5.21
High today$5.21
Low today
$4.12
Low today$4.12
Open price
$4.21
Open price$4.21
Volume
191.33K
Volume191.33K
52 Week high
$5.21
52 Week high$5.21
52 Week low
$2.22
52 Week low$2.22

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.